{"name": "Calistoga Pharmaceuticals",
 "permalink": "calistoga-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/calistoga-pharmaceuticals",
 "homepage_url": "http://www.calistogapharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "Calistoga Pharmaceuticals, Inc.",
 "email_address": "",
 "phone_number": "206-728-4700",
 "description": "Cancer \u0026 Inflammatory Disease Treatment",
 "created_at": "Tue Jul 07 20:25:39 UTC 2009",
 "updated_at": "Wed Feb 23 05:50:13 UTC 2011",
 "overview": "\u003Cp\u003ECalistoga Pharmaceuticals is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases. Calistoga Pharmaceuticals has a portfolio of proprietary compounds selectively targeting the isoforms of the PI3 kinase pathway.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       85],
      "assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],
     [[217,
       124],
      "assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],
     [[217,
       124],
      "assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Andrew",
      "last_name": "Guggenhime",
      "permalink": "andrew-guggenhime",
      "image": null}},
   {"is_past": true,
    "title": "President and CEO",
    "person":
     {"first_name": "Carol",
      "last_name": "Gallagher",
      "permalink": "carol-gallagher",
      "image": null}},
   {"is_past": true,
    "title": "Senior Director, Finance",
    "person":
     {"first_name": "Tom",
      "last_name": "Swallow",
      "permalink": "tom-swallow",
      "image":
       {"available_sizes":
         [[[90,
            100],
           "assets/images/resized/0026/4426/264426v1-max-150x150.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4426/264426v1-max-250x250.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4426/264426v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$91M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "",
    "source_description": "Capital Report Index",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://calistogapharma.com/pdf/CalistogaFinancing_March2007.pdf",
    "source_description": "Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing",
    "raised_amount": 21000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 3,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.calistogapharma.com/pdf/FINAL%20CALPharma%20Series%20C%20release%206.30.10.pdf",
    "source_description": "Calistoga Pharmaceuticals Raises $40 Million in Series C Financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Quogue Capital",
         "permalink": "quogue-capital",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Latterell Venture Partners",
         "permalink": "latterell-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0005/5132/55132v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0005/5132/55132v2-max-250x250.png"],
             [[287,
               42],
              "assets/images/resized/0005/5132/55132v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 375000000.0,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://investors.gilead.com/preview/phoenix.zhtml?c=69964\u0026p=irol-newsArticle\u0026ID=1531190\u0026highlight=",
   "source_description": "Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million",
   "acquired_year": 2011,
   "acquired_month": 2,
   "acquired_day": 22,
   "acquiring_company":
    {"name": "Gilead Sciences",
     "permalink": "gilead-sciences",
     "image":
      {"available_sizes":
        [[[150,
           41],
          "assets/images/resized/0009/1771/91771v1-max-150x150.png"],
         [[185,
           51],
          "assets/images/resized/0009/1771/91771v1-max-250x250.png"],
         [[185,
           51],
          "assets/images/resized/0009/1771/91771v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2101 4th Avenue, Suite 1960",
    "address2": "",
    "zip_code": "98121",
    "city": "Seattle",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        95],
       "assets/images/resized/0006/4216/64216v1-max-150x150.jpg"],
      [[250,
        159],
       "assets/images/resized/0006/4216/64216v1-max-250x250.jpg"],
      [[450,
        287],
       "assets/images/resized/0006/4216/64216v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}